Search results
Results from the WOW.Com Content Network
The Medicaid Drug Rebate Program is a program in the United States that was created by the Omnibus Budget Reconciliation Act of 1990 (OBRA'90). The program establishes mandatory rebates that drug manufacturers must pay state Medicaid agencies related to the dispensing of outpatient prescription drugs covered by Medicaid .
Of the 1.9 million people in Florida who lost Medicaid coverage, according to KFF, patient advocates estimate that thousands of disabled people like Eakin have been affected.
In 2020, there was a 25.8% increase in opioid overdose cases and a 38% increase in overdose deaths in the Rochester area (Monroe County). Concern over the overdose growth has led to legislators introducing legislation in the state Assembly that would require pharmacies to offer a dose of naloxone to individuals receiving an opioid prescription.
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
The report found that 8 in 10 calls to Florida's Medicaid call center were automatically disconnected from the phone system. When people managed to get through, there were long delays to reach ...
Medicaid is a government program in the United States that provides health insurance for adults and children with limited income and resources. The program is partially funded and primarily managed by state governments, which also have wide latitude in determining eligibility and benefits, but the federal government sets baseline standards for state Medicaid programs and provides a significant ...
This program caps monthly premium increases to $35 in 2024 and 2025. So, at most, standalone drug plan premiums could increase by $35 per month over 2024 levels. But some plans may have more ...
N-Phenethylnormorphine is an opioid analgesic drug derived from morphine by replacing the N-methyl group with β-phenethyl. [1] It is around eight to fourteen times more potent than morphine as a result of this modification, [2] in contrast to most other N-substituted derivatives of morphine, which are substantially less active, or act as antagonists. [3]